Expression of stromelysin-3 in medullary carcinoma of the breast

被引:0
|
作者
Holm, R [1 ]
Florenes, VA
Erikstein, B
Nesland, JM
机构
[1] Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[2] Norwegian Radium Hosp, Dept Tumorbiol, N-0310 Oslo, Norway
[3] Norwegian Radium Hosp, Dept Med Oncol, N-0310 Oslo, Norway
[4] Inst Canc Res, N-0310 Oslo, Norway
关键词
breast; in situ hybridization; medullary carcinomas; stromelysin-3;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinases are belived to play a central role in the invasion and metastasis of human cancers by mediating the degration of extracellular matrix components. Expression of stromelysin-3 (ST3), a new member of matrix metalloproteinase family, was investigated by in situ hybridization in 32 tissue samples of medullary carcinoma of the breast. Eighty-four per cent of the cases showed ST3 gene expression in stromal cells adjacent to tumor cells. Therefore, expression of ST3 in stromal cells may be expected to play a significant role in the destruction of extracellular matrix and invasion of medullary carcinoma of the breast.
引用
收藏
页码:3725 / 3727
页数:3
相关论文
共 50 条
  • [1] Stromelysin-3 expression: an independent prognostic marker in node positive breast carcinoma
    Ahmad, A
    Hanby, AM
    Dublin, EA
    Bassett, P
    Hart, IR
    JOURNAL OF PATHOLOGY, 1998, 184 : 23A - 23A
  • [2] EXPRESSION OF STROMELYSIN-3 AND NM23 IN BREAST-CARCINOMA AND RELATED-TISSUES
    HAHNEL, E
    DAWKINS, H
    ROBBINS, P
    HAHNEL, R
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) : 157 - 160
  • [3] Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis
    Têtu, B
    Brisson, J
    Wang, CS
    Lapointe, H
    Beaudry, G
    Blanchette, C
    CANCER, 2001, 92 (11) : 2957 - 2964
  • [4] CHARACTERIZATION OF MONOCLONAL-ANTIBODIES AGAINST STROMELYSIN-3 AND THEIR USE TO EVALUATE STROMELYSIN-3 LEVELS IN BREAST-CARCINOMA BY SEMIQUANTITATIVE IMMUNOHISTOCHEMISTRY
    SANTAVICCA, M
    NOEL, A
    CHENARD, MP
    LUTZ, Y
    STOLL, I
    SEGAIN, JP
    ROUYER, N
    RIO, MC
    WOLF, C
    BELLOCQ, JP
    BASSET, P
    INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (05) : 336 - 341
  • [5] STROMELYSIN-3 EXPRESSION IN BREAST-CANCER BIOPSIES - CLINICOPATHOLOGICAL CORRELATIONS
    HAHNEL, E
    HARVEY, JM
    JOYCE, R
    ROBBINS, PD
    STERRETT, GF
    HAHNEL, R
    INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (05) : 771 - 774
  • [6] High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma
    Chenard, MP
    OSiorain, L
    Shering, S
    Rouyer, N
    Lutz, Y
    Wolf, C
    Basset, P
    Bellocq, JP
    Duffy, MJ
    INTERNATIONAL JOURNAL OF CANCER, 1996, 69 (06) : 448 - 451
  • [7] Stromelysin-3 as a new prognostic marker in breast cancer
    Chenard, MP
    Mechine, A
    Lang-Averous, G
    Basset, P
    Bellocq, JP
    MODERN PATHOLOGY, 1998, 11 (01) : 17A - 17A
  • [8] Stromelysin-3 as a new prognostic marker in breast cancer
    Chenard, MP
    Mechine, A
    Lang-Averous, G
    Basset, P
    Bellocq, JP
    LABORATORY INVESTIGATION, 1998, 78 (01) : 17A - 17A
  • [9] EXPRESSION OF STROMELYSIN-3 IN THE HUMAN IMPLANTATION PLACENTAL SITE
    MAQUOI, E
    POLETTE, M
    NAWROCKI, B
    BISCHOF, P
    NOEL, A
    PINTIAUX, A
    BIREMBAUT, P
    BASSET, P
    FOIDART, JM
    CELL BIOLOGY INTERNATIONAL, 1995, 19 (03) : 249 - 249
  • [10] Clinicopathological significance of stromelysin-3 expression in colorectal cancer
    Skoglund, J
    Emterling, A
    Arbman, G
    Anglard, P
    Sun, XF
    ONCOLOGY, 2004, 67 (01) : 67 - 72